Mount Sinai Mobile Interventional Stroke Team Travels to Patients, Resulting in Faster Treatment and Better Outcomes

Study finds stroke patients are nearly twice as likely to be functionally independent if treated by a specialized team that travels to them to perform surgical clot removal

Wayne State receives $2.6 million research award from American Heart Association

Black adults have a higher incidence of hypertension (HTN) and a greater risk of HTN-related cardiovascular disease compared to white adults. Even mild elevations in blood pressure are associated with an increased risk for cardiovascular disease; therefore, early interventions for high blood pressure and hypertension are critical to assist in recommendations for lifestyle modification.

Two Mount Sinai Leaders Receive Prestigious Honors from American Heart Association in New York City

Two of Mount Sinai’s top doctors will be honored with prestigious awards at the American Heart Association’s New York City Heart and Stroke Ball, taking place virtually on Wednesday, June 9.

American Heart Month: FSU experts available to comment on heart disease topics

By: Kelsey Klopfenstein | Published: February 3, 2021 | 1:14 pm | SHARE: Heart disease is the leading cause of death in the United States. Someone has a heart attack every 39 seconds, and cardiovascular disease claims more lives each year than all forms of cancer combined, according to the American Heart Association’s 2021 Heart Disease and Stroke Statistics Update.

UChicago Medicine receives recognition for resuscitation and stroke care

The American Heart Association has recognized Comer Children’s Hospital with its top honor for resuscitation care of newborns and children, and University of Chicago Medicine with its top honor for stroke care. The awards reflect commitment to high-quality, advanced care for children and adults.

New Research Supports Initial Conservative Management of Stable Coronary Artery Disease

New study results confirm that guideline-directed medical therapy is as effective as more invasive procedures at preventing death, stroke, and heart attack in patients with stable coronary artery disease (CAD).

The study results suggest that guideline-directed medical therapy should be the initial treatment strategy for patients with stable CAD.

The study results validate the evidence-based, guideline-directed, conservative treatment approach that the cardiovascular specialists at Nuvance Health have always used to treat CAD.

15-Year Study Finds Treatment Gaps Exist for Patients with Peripheral Arterial Disease; More Consistent Use of Life-Saving Medications Recommended

A new 15-year study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that patients with peripheral arterial disease may not be prescribed life-saving medications at the same rate as for other heart conditions.

Researchers Discover New Mutations in Gene Associated with Disease That Causes Weakening of the Heart

Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood to meet the body’s needs.

“Nudging” Heart Patients to Take Their Statins Leads to Better Medication Adherence and Better Patient Outcomes

In a new study presented to heart specialists from around the world, researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that simple “nudges” in the form of texts, emails and phone calls, not only help patients fill that first statin prescription, but also continue to help them take their medications over the long term.